Manufacturer
AstraZeneca
Contents
Saxagliptin HCl
Indication
In monotherapy, as an adjunct to diet & exercise to improve glycemic control in patients w/ type 2 DM. In combination therapy with metformin as initial therapy; or in combination w/ metformin, sulphonylurea, thiazolidinedione or insulin (w/ or w/o metformin) when these compd alone do not provide adequate glycaemic control. Triple oral therapy in combination w/ metformin plus a sulphonylurea.
Instruction
May be taken with or without food: Do not split/cut tab.
Drug interaction
Increased plasma conc w/ strong CYP3A4/5 inhibitors (eg, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir & telithromycin).
Malaysia
